Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia

Acute myeloid leukaemia (AML) is a heterogeneous disease with one of the worst survival rates of all cancers. The bone marrow microenvironment is increasingly being recognised as an important mediator of AML chemoresistance and relapse, supporting leukaemia stem cell survival through interactions am...

Descripción completa

Detalles Bibliográficos
Autores principales: Skelding, Kathryn A., Barry, Daniel L., Theron, Danielle Z., Lincz, Lisa F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820412/
https://www.ncbi.nlm.nih.gov/pubmed/36614005
http://dx.doi.org/10.3390/ijms24010563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820412/
https://www.ncbi.nlm.nih.gov/pubmed/36614005
http://dx.doi.org/10.3390/ijms24010563

Ejemplares similares